A phase II study to determine the efficacy, safety, tolerability, and pharmacokinetics of a controlled release (CR) formulation of mazindol in adults with attention-deficit/hyperactivity disorder (ADHD)
Journal of the American Academy of Child & Adolescent Psychiatry | Oct 29, 2017
Efficacy and safety of SHP465 mixed amphetamine salts in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): A randomized, placebo-controlled study
Journal of the American Academy of Child & Adolescent Psychiatry | Oct 29, 2017
Short- and long-term prolonged release melatonin treatment for sleep disorders in children with autism spectrum disorders â Results of a phase III randomized clinical trial
Journal of the American Academy of Child & Adolescent Psychiatry | Oct 28, 2017
Benefits of very low dose fluoxetine in children with autism spectrum disorders
Journal of the American Academy of Child & Adolescent Psychiatry | Oct 28, 2017